Drug shortage
Alteplase Injection · Genentech, Inc
FDA drug shortage · To Be Discontinued · updated May 21, 2026
Key facts
| Generic name | Alteplase Injection |
|---|---|
| Company | Genentech, Inc |
| Presentation | Activase, Injection, 1 KIT in 1 CARTON (50242-085-27) * 100 mL in 1 VIAL, SINGLE-USE * 100 mL in 1 VIAL, SINGLE USE (NDC 50242-085-27) |
| Dosage form | Injection |
| Status | To Be Discontinued |
| Therapeutic category | Cardiovascular Hematology Neurology |
| Package NDCs | 50242-085-27 |
| First posted | May 21, 2026 |
| Last updated | May 21, 2026 |
| Discontinued | May 21, 2026 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: